These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Angiotensin-converting enzyme inhibitors in patients with preserved left ventricular function: from EUROPA to PREAMI]. Ferrari R; Papa K; Bernocchi P; Gimbatti OJ; Golcea SS; Bettini A; Ceconi C Ital Heart J; 2005 Nov; 6 Suppl 7():24S-32S. PubMed ID: 16485514 [TBL] [Abstract][Full Text] [Related]
25. [Modification of hemodynamics by angiotensin converting enzyme inhibitors in heart failure]. Ertl G; Gaudron P; Eilles C Herz; 1990 Jun; 15(3):158-63. PubMed ID: 2198216 [TBL] [Abstract][Full Text] [Related]
26. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials. Danchin N; Cucherat M; Thuillez C; Durand E; Kadri Z; Steg PG Arch Intern Med; 2006 Apr; 166(7):787-96. PubMed ID: 16606817 [TBL] [Abstract][Full Text] [Related]
27. Progress in angiotensin-converting enzyme inhibition in heart failure: rationale, mechanisms, and clinical responses. Dzau VJ; Creager MA Cardiol Clin; 1989 Feb; 7(1):119-30. PubMed ID: 2650868 [TBL] [Abstract][Full Text] [Related]
29. The extent of regional wall motion abnormalities identifies patients at risk of extensive left ventricular remodeling: implications for the design of post myocardial infarction trials. Zanolla L; Marino P; Golia G; Anselmi M; Zardini P; Borghi C; Ambrosioni E G Ital Cardiol; 1999 Jan; 29(1):20-6. PubMed ID: 9987043 [TBL] [Abstract][Full Text] [Related]
30. Issues concerning the use of angiotensin-converting enzyme inhibitors in the treatment of heart failure and myocardial infarction. Poole-Wilson PA Arch Mal Coeur Vaiss; 1994 Jun; 87 Spec No 2():35-8. PubMed ID: 7864720 [No Abstract] [Full Text] [Related]
31. Development and prevention of congestive heart failure following myocardial infarction. Pfeffer MA; Pfeffer JM; Lamas GA Circulation; 1993 May; 87(5 Suppl):IV120-5. PubMed ID: 8485827 [TBL] [Abstract][Full Text] [Related]
32. Prevention of ventricular remodelling post myocardial infarction: timing and duration of therapy. Jugdutt BI Can J Cardiol; 1993; 9(1):103-14. PubMed ID: 8439824 [TBL] [Abstract][Full Text] [Related]
33. [Current aspects of ACE inhibitor therapy from the cardiologic viewpoint]. Klein W; Eber B; Gasser R; Stoschitzky K; Schumacher M; Fruhwald FM; Zweiker R Wien Med Wochenschr; 1996; 146(11):221-4. PubMed ID: 8928518 [TBL] [Abstract][Full Text] [Related]
34. [Growth stimulating properties of angiotensin II on the heart: consequences for therapy of heart failure]. Schunkert H; Holmer SR; Riegger G Z Kardiol; 1993; 82 Suppl 4():1-6. PubMed ID: 8147057 [TBL] [Abstract][Full Text] [Related]